Business

Alto Neuroscience to Participate in Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., October 28, 2025--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will present at the following upcoming investor conferences:

articleAlto Neuroscience, Inc.October 28, 20252/company/alto-neuroscience-inc/news/alto-neuroscience-participate-upcoming-investor-113400832
Alto Neuroscience to Participate in Upcoming Investor Conferences

About this update from Alto Neuroscience, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1659,"height":537,"url":"https://media.zenfs.com/en/business-wire.com/2b3fb088d2e0d56cda8bca37951292a7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/slKHqeykWmLdYYnmG91_XQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMxMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/2b3fb088d2e0d56cda8bca37951292a7","width":960,"height":311},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/doayyk9WZgMNKSY.I6e6Uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NzY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/2b3fb088d2e0d56cda8bca37951292a7","width":1200,"height":388}},"lazy":false},{"type":"text","content":"MOUNTAIN VIEW, Calif., October 28, 2025--(BUSINESS WIRE)--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will present at the following upcoming investor conferences:","length":367,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Stifel 2025 Healthcare Conference, November 11-13, 2025","length":55,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Format: Fireside chat and one-on-one meetings","length":45,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Presentation Date & Time: Wednesday, November 12 at 10:00-10:30 AM ET","length":73,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Location: New York, New York","length":28,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":146,"olType":false}]}],"tagName":"ul","bulletedList":true,"length":201,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Jefferies London Healthcare Conference, November 17-20, 2025","length":60,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Format: Fireside chat and one-on-one investor meetings","length":54,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Presentation Date & Time: Monday, November 17 at 3:30-3:55 PM GMT","length":69,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Location: London, UK","length":20,"tagNam...

More updates from Alto Neuroscience, Inc.

Healthcare Conferencebiopharmaceutical companyAlto NeuroscienceJefferies London Healthcare ConferenceFireside chat